BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27345998)

  • 1. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
    Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
    Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
    Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
    Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
    Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1.
    Poon A; Schmid B; Pires C; Nielsen TT; Hjermind LE; Nielsen JE; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):466-469. PubMed ID: 27789395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
    Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient.
    Hauser S; Erzler M; Theurer Y; Schuster S; Schüle R; Schöls L
    Stem Cell Res; 2016 Nov; 17(3):485-488. PubMed ID: 27789400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
    Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
    Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
    Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
    Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblast-derived integration-free iPS cell line from a 65-year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
    Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Jan; 16(1):113-5. PubMed ID: 27345793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia.
    Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
    Stem Cell Res; 2016 Jan; 16(1):105-9. PubMed ID: 27345791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
    Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
    Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
    Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT).
    Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
    Stem Cell Res; 2016 Jan; 16(1):75-8. PubMed ID: 27345789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP gene.
    Toustrup LB; Zhou Y; Kvistgaard H; Gregersen N; Rittig S; Aagaard L; Corydon TJ; Luo Y; Christensen JH
    Stem Cell Res; 2017 Mar; 19():37-42. PubMed ID: 28413003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT).
    Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
    Stem Cell Res; 2016 Jan; 16(1):70-4. PubMed ID: 27345788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood mononuclear cell-converted induced pluripotent stem cells (iPSCs) from an early onset Alzheimer's patient.
    Lee HK; Morin P; Xia W
    Stem Cell Res; 2016 Mar; 16(2):213-5. PubMed ID: 27345971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.